GB0015835D0 - Compounds useful in therapy - Google Patents

Compounds useful in therapy

Info

Publication number
GB0015835D0
GB0015835D0 GB0015835A GB0015835A GB0015835D0 GB 0015835 D0 GB0015835 D0 GB 0015835D0 GB 0015835 A GB0015835 A GB 0015835A GB 0015835 A GB0015835 A GB 0015835A GB 0015835 D0 GB0015835 D0 GB 0015835D0
Authority
GB
United Kingdom
Prior art keywords
therapy
compounds useful
compounds
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0015835A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0015835A priority Critical patent/GB0015835D0/en
Publication of GB0015835D0 publication Critical patent/GB0015835D0/en
Priority to EEP200200656A priority patent/EE05110B1/en
Priority to YUP82202 priority patent/RS50904B/en
Priority to PCT/IB2001/000806 priority patent/WO2001090106A2/en
Priority to SI200130090T priority patent/SI1284974T1/en
Priority to AT01925808T priority patent/ATE260914T1/en
Priority to KR1020057003492A priority patent/KR100548854B1/en
Priority to DK04004193T priority patent/DK1526134T3/en
Priority to HU0302474A priority patent/HU225810B1/en
Priority to CA 2408909 priority patent/CA2408909C/en
Priority to AU5248201A priority patent/AU5248201A/en
Priority to MXPA02011631A priority patent/MXPA02011631A/en
Priority to SI200130862T priority patent/SI1526134T1/en
Priority to AU2001252482A priority patent/AU2001252482B2/en
Priority to JP2001586293A priority patent/JP3693957B2/en
Priority to EA200201141A priority patent/EA005382B1/en
Priority to BRPI0110955A priority patent/BRPI0110955B8/en
Priority to AT04004193T priority patent/ATE407134T1/en
Priority to CZ20023806A priority patent/CZ299102B6/en
Priority to ES04004193T priority patent/ES2311126T3/en
Priority to DK01925808T priority patent/DK1284974T3/en
Priority to SK1643-2002A priority patent/SK286129B6/en
Priority to OA1200200343A priority patent/OA12264A/en
Priority to DE2001602233 priority patent/DE60102233T2/en
Priority to RSP-2009/0438A priority patent/RS51436B/en
Priority to DE200812000011 priority patent/DE122008000011I1/en
Priority to CNB018088287A priority patent/CN1279040C/en
Priority to ES08163025T priority patent/ES2401812T3/en
Priority to DE60135685T priority patent/DE60135685D1/en
Priority to CNB2005100068151A priority patent/CN100355753C/en
Priority to PT01925808T priority patent/PT1284974E/en
Priority to PL359267A priority patent/PL200551B1/en
Priority to EP20080163025 priority patent/EP1990341B1/en
Priority to EA200401056A priority patent/EA007580B1/en
Priority to IL15253101A priority patent/IL152531A0/en
Priority to GEAP2001004960 priority patent/GEP20063799B/en
Priority to EP20040004193 priority patent/EP1526134B1/en
Priority to MEP-693/08A priority patent/ME00555A/en
Priority to CN2006100735840A priority patent/CN1830445B/en
Priority to TR200400541T priority patent/TR200400541T4/en
Priority to PT04004193T priority patent/PT1526134E/en
Priority to KR10-2002-7015934A priority patent/KR100523501B1/en
Priority to NZ521477A priority patent/NZ521477A/en
Priority to ES01925808T priority patent/ES2215129T3/en
Priority to DZ013464A priority patent/DZ3464A1/fr
Priority to APAP/P/2002/002663A priority patent/AP1965A/en
Priority to EP20010925808 priority patent/EP1284974B1/en
Priority to TW90112055A priority patent/TWI230160B/en
Priority to PA8517101A priority patent/PA8517101A1/en
Priority to EG20010535A priority patent/EG24137A/en
Priority to MYPI20094132A priority patent/MY156920A/en
Priority to MYPI20041980 priority patent/MY153023A/en
Priority to MYPI20012461 priority patent/MY131019A/en
Priority to ARP010102486 priority patent/AR028622A1/en
Priority to UY26727A priority patent/UY26727A1/en
Priority to PE2001000476A priority patent/PE20011371A1/en
Priority to US09/865,950 priority patent/US6667314B2/en
Priority to TNSN01077 priority patent/TNSN01077A1/en
Priority to BG107140A priority patent/BG65966B1/en
Priority to IS6565A priority patent/IS2511B/en
Priority to CU20020243A priority patent/CU23288B7/en
Priority to IL152531A priority patent/IL152531A/en
Priority to NO20025227A priority patent/NO327892B1/en
Priority to MA26910A priority patent/MA26902A1/en
Priority to HR20020938A priority patent/HRP20020938B1/en
Priority to HK03107045A priority patent/HK1054927A1/en
Priority to US10/678,836 priority patent/US7368460B2/en
Priority to JP2005038062A priority patent/JP4854970B2/en
Priority to HK05110416A priority patent/HK1078573A1/en
Priority to HK06111446A priority patent/HK1090836A1/en
Priority to ARP070101273 priority patent/AR060159A2/en
Priority to US12/023,334 priority patent/US7576097B2/en
Priority to NL300338C priority patent/NL300338I2/en
Priority to LU91417C priority patent/LU91417I2/en
Priority to LTPA2008004C priority patent/LTC1284974I2/en
Priority to FR08C0007C priority patent/FR08C0007I2/en
Priority to CY200800006C priority patent/CY2008006I2/en
Priority to CR10145A priority patent/CR10145A/en
Priority to CY081101203T priority patent/CY1108451T1/en
Priority to NO2010007C priority patent/NO2010007I2/en
Priority to NO2020019C priority patent/NO2020019I1/en
Ceased legal-status Critical Current

Links

GB0015835A 2000-05-26 2000-06-27 Compounds useful in therapy Ceased GB0015835D0 (en)

Priority Applications (81)

Application Number Priority Date Filing Date Title
GB0015835A GB0015835D0 (en) 2000-06-27 2000-06-27 Compounds useful in therapy
EEP200200656A EE05110B1 (en) 2000-05-26 2001-05-09 3- (3-Isopropyl-5-methyl-4H-1,2,4-triazol-4-yl) -exo-8-azabicyclo [3.2.1] octane derivatives, derivatives of such derivatives methods of preparation, intermediates used in their preparation, compositions and combinations containing such derivatives; and
YUP82202 RS50904B (en) 2000-05-26 2001-05-09 Tropane derivatives useful in therapy
PCT/IB2001/000806 WO2001090106A2 (en) 2000-05-26 2001-05-09 Tryasolyl tropane derivatives as ccr5 modulators
SI200130090T SI1284974T1 (en) 2000-05-26 2001-05-09 Triazolyl tropane derivatives as ccr5 modulators
AT01925808T ATE260914T1 (en) 2000-05-26 2001-05-09 TRIAZOLYLTROPAND DERIVATIVES AS CCR5 MODULATORS
KR1020057003492A KR100548854B1 (en) 2000-05-26 2001-05-09 Tryasolyl Tropane Derivatives as CCR5 Modulators
DK04004193T DK1526134T3 (en) 2000-05-26 2001-05-09 Triazolyltropane derivatives as CCR5 modulators
HU0302474A HU225810B1 (en) 2000-05-26 2001-05-09 Therapeutically effective tropane derivatives, process for their preparation pharmaceutical compositions containing them and their use
CA 2408909 CA2408909C (en) 2000-05-26 2001-05-09 Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators
AU5248201A AU5248201A (en) 2000-05-26 2001-05-09 Tropane derivatives useful in therapy
MXPA02011631A MXPA02011631A (en) 2000-05-26 2001-05-09 Tryasolyl tropane derivatives as ccr5 modulators.
SI200130862T SI1526134T1 (en) 2000-05-26 2001-05-09 Triazolyl tropane derivatives as ccr5 modulators
AU2001252482A AU2001252482B2 (en) 2000-05-26 2001-05-09 Triazolyl Tropane Derivatives As CCR5 Modulators
JP2001586293A JP3693957B2 (en) 2000-05-26 2001-05-09 Tropane derivatives useful in therapy
EA200201141A EA005382B1 (en) 2000-05-26 2001-05-09 Tropane derivatives useful in therapy
BRPI0110955A BRPI0110955B8 (en) 2000-05-26 2001-05-09 tropane derivatives pharmaceutical composition, their use in the manufacture of a drug as well as a process for their preparation.
AT04004193T ATE407134T1 (en) 2000-05-26 2001-05-09 TRIAZOLYLTROPAND DERIVATIVES AS CCR5 MODULATORS
CZ20023806A CZ299102B6 (en) 2000-05-26 2001-05-09 Tropane derivative, methods and intermediates for its preparation, medicaments and therapeutic combinations containing thereof
ES04004193T ES2311126T3 (en) 2000-05-26 2001-05-09 DERIVATIVES OF TRIAZOLIL TROPANO AS MODULATORS OF CCR5.
DK01925808T DK1284974T3 (en) 2000-05-26 2001-05-09 Triazolyltropane derivatives as CCR5 modulators
SK1643-2002A SK286129B6 (en) 2000-05-26 2001-05-09 Tropane derivatives, their use, a method for their preparation, an intermediate, a combination and a pharmaceutical composition containing thereof
OA1200200343A OA12264A (en) 2000-05-26 2001-05-09 Tryasolyl tropane derivatives as CCR5 modulators.
DE2001602233 DE60102233T2 (en) 2000-05-26 2001-05-09 TRIAZOLYLTROPAN DERIVATIVES AS CCR5 MODULATORS
RSP-2009/0438A RS51436B (en) 2000-05-26 2001-05-09 Triazol tropane derivatives as ccr5 moudlators
DE200812000011 DE122008000011I1 (en) 2000-05-26 2001-05-09 TRIAZOLYLTROPAN DERIVATIVES AS CCR5 MODULATORS
CNB018088287A CN1279040C (en) 2000-05-26 2001-05-09 Tryasolyl tropane derivatives for therapy
ES08163025T ES2401812T3 (en) 2000-05-26 2001-05-09 Triazolyl tropane derivatives as CCR5 modulators
DE60135685T DE60135685D1 (en) 2000-05-26 2001-05-09 TRIAZOLYLTROPAN DERIVATIVES AS CCR5 MODULATORS
CNB2005100068151A CN100355753C (en) 2000-05-26 2001-05-09 Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds
PT01925808T PT1284974E (en) 2000-05-26 2001-05-09 TRIAZOLYLPHOLE DERIVATIVES AS CCR5 MODULATORS
PL359267A PL200551B1 (en) 2000-05-26 2001-05-09 Triazolyl tropane derivatives as ccr5 modulators
EP20080163025 EP1990341B1 (en) 2000-05-26 2001-05-09 Triazolyl tropane derivatives as CCR5 modulators
EA200401056A EA007580B1 (en) 2000-05-26 2001-05-09 Combination containing tropane derivatives useful in therapy
IL15253101A IL152531A0 (en) 2000-05-26 2001-05-09 Tropane derivatives useful in therapy
GEAP2001004960 GEP20063799B (en) 2000-05-26 2001-05-09 Tropane derivatives useful in therapy
EP20040004193 EP1526134B1 (en) 2000-05-26 2001-05-09 Triazolyl tropane derivatives as ccr5 modulators
MEP-693/08A ME00555A (en) 2000-05-26 2001-05-09 Tryasolyl tropane derivatives as ccr5 modulators
CN2006100735840A CN1830445B (en) 2000-05-26 2001-05-09 Composition of tropane derivatives having therapy use and polymorph thereof
TR200400541T TR200400541T4 (en) 2000-05-26 2001-05-09 Tropan derivatives useful in therapy.
PT04004193T PT1526134E (en) 2000-05-26 2001-05-09 Triazolyl tropane derivatives as ccr5 modulators
KR10-2002-7015934A KR100523501B1 (en) 2000-05-26 2001-05-09 Tryasolyl Tropane Derivatives as CCR5 Modulators
NZ521477A NZ521477A (en) 2000-05-26 2001-05-09 Tropane derivatives useful in therapy
ES01925808T ES2215129T3 (en) 2000-05-26 2001-05-09 DERIVATIVES OF TRIAZOLIL TROPANO AS MODULAR OF CCR5.
DZ013464A DZ3464A1 (en) 2000-05-26 2001-05-09
APAP/P/2002/002663A AP1965A (en) 2000-05-26 2001-05-09 Tropane derivatives useful in therapy.
EP20010925808 EP1284974B1 (en) 2000-05-26 2001-05-09 Triazolyl tropane derivatives as ccr5 modulators
TW90112055A TWI230160B (en) 2000-05-26 2001-05-21 Tropane derivatives useful in therapy
PA8517101A PA8517101A1 (en) 2000-05-26 2001-05-22 USEFUL TROPANO DERIVATIVES IN THERAPY
EG20010535A EG24137A (en) 2000-05-26 2001-05-22 Tropane derivatives useful in therapy
MYPI20094132A MY156920A (en) 2000-05-26 2001-05-23 Tropane derivatives useful in therapy
MYPI20041980 MY153023A (en) 2000-05-26 2001-05-23 Tropane derivatives useful in therapy
MYPI20012461 MY131019A (en) 2000-05-26 2001-05-23 Tropane derivatives useful in therapy
ARP010102486 AR028622A1 (en) 2000-05-26 2001-05-24 USEFUL TROPANO DERIVATIVES IN THERAPY
UY26727A UY26727A1 (en) 2000-05-26 2001-05-24 USEFUL TROPANIC DERIVATIVES IN THERAPY
PE2001000476A PE20011371A1 (en) 2000-05-26 2001-05-24 DERIVATIVES OF 3- (3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-IL) -EXO-8-AZABICYCLO [3.2.1] OCTANE AS ANTAGONISTS OF CCR5 CHEMOKIN RECEPTORS
US09/865,950 US6667314B2 (en) 2000-05-26 2001-05-25 Tropane derivatives useful in therapy
TNSN01077 TNSN01077A1 (en) 2000-05-26 2001-05-25 NEW TROPANE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
BG107140A BG65966B1 (en) 2000-05-26 2002-09-23 Tropane derivatives useful in therapy
IS6565A IS2511B (en) 2000-05-26 2002-09-24 Triazolyl tropane derivatives which CCR5 adjusts
CU20020243A CU23288B7 (en) 2000-05-26 2002-10-28 TROPANIC DERIVATIVES IN THERAPY
IL152531A IL152531A (en) 2000-05-26 2002-10-28 8 - (3 - carboxamido - 3 - phenylpropyl) - 3 - (3 - isopropyl - 5 - methyl - 4h - 1,2,4 - triazol - 4 - yl) - tropane derivatives, medicaments containing them, their preparation and some new intermediates thereof
NO20025227A NO327892B1 (en) 2000-05-26 2002-10-31 Tropane derivatives useful in therapy
MA26910A MA26902A1 (en) 2000-05-26 2002-11-14 TRIAZOLYLTROPANE DERIVATIVES USEFUL AS CCR5 MODULATORS
HR20020938A HRP20020938B1 (en) 2000-05-26 2002-11-26 Tropane derivatives useful in therapy
HK03107045A HK1054927A1 (en) 2000-05-26 2003-09-30 Tropane derivatives useful in therapy
US10/678,836 US7368460B2 (en) 2000-05-26 2003-10-03 Tropane derivatives useful in therapy
JP2005038062A JP4854970B2 (en) 2000-05-26 2005-02-15 Tropane derivatives useful in therapy
HK05110416A HK1078573A1 (en) 2000-05-26 2005-11-18 Tropane derivatives usefull in therapy
HK06111446A HK1090836A1 (en) 2000-05-26 2006-10-18 Intermediates for the preparation of tropane derivatives useful in therapy
ARP070101273 AR060159A2 (en) 2000-05-26 2007-03-27 COMBINATIONS OF COMPOUNDS DERIVED FROM USEFUL TROPANE IN THERAPY
US12/023,334 US7576097B2 (en) 2000-05-26 2008-01-31 Tropane derivatives useful in therapy
NL300338C NL300338I2 (en) 2000-05-26 2008-02-22 Triazolytropane derivatives as ccr5 modulators
LU91417C LU91417I2 (en) 2000-05-26 2008-02-22 "Maraviroc, optionally in the form of a pharmaceutically acceptable salt CELSENTRI"
LTPA2008004C LTC1284974I2 (en) 2000-05-26 2008-02-25 Triazolyltropane derivatives as CCR5 modulators
FR08C0007C FR08C0007I2 (en) 2000-05-26 2008-03-04 TRIAZOLYLTROPANE DERIVATIVES USED AS CCR5 MODULATORS
CY200800006C CY2008006I2 (en) 2000-05-26 2008-03-17 TROPANE DERIVATIVES USEFUL IN THERAPEUTICS
CR10145A CR10145A (en) 2000-05-26 2008-07-16 USEFUL TROPANAN DERIVATIVES IN THERAPY (DIVISIONAL EXP. 6800)
CY081101203T CY1108451T1 (en) 2000-05-26 2008-10-24 TRIAZOLYLOTROPANI PRODUCTS AS REGULATORS CCR5
NO2010007C NO2010007I2 (en) 2000-05-26 2010-04-08 N- (IS) -3-I3-isopropyl-5-methyl-4H-1,2,4-Triosol-4-yl) -exo-8-azabicyclo [3.2.1] oct-8-yl] -1- phenylpropyl-4,4-difluorcykloheksankarboksamid
NO2020019C NO2020019I1 (en) 2000-05-26 2020-06-30 Maraviroc optionally in the form of a pharmaceutically acceptable salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0015835A GB0015835D0 (en) 2000-06-27 2000-06-27 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
GB0015835D0 true GB0015835D0 (en) 2000-08-23

Family

ID=9894581

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0015835A Ceased GB0015835D0 (en) 2000-05-26 2000-06-27 Compounds useful in therapy

Country Status (1)

Country Link
GB (1) GB0015835D0 (en)

Similar Documents

Publication Publication Date Title
GB0016787D0 (en) Compounds useful in therapy
GB9912411D0 (en) Compounds useful in therapy
EP1296697A4 (en) Therapeutic agents - i
GB0028429D0 (en) Therapy
GB9912413D0 (en) Compounds useful in therapy
GB0008710D0 (en) Therapeutic compounds
GB0009606D0 (en) Therapeutic combinations
GB0016681D0 (en) Therapeutic compounds
GB9912410D0 (en) Compounds useful in therapy
GB9912415D0 (en) Compounds useful in therapy
GB9912416D0 (en) Compounds useful in therapy
GB0014046D0 (en) Compounds useful in therapy
GB0014866D0 (en) Compounds useful in therapy
GB0015835D0 (en) Compounds useful in therapy
GB9906130D0 (en) Compounds for use in therapy
GB0013105D0 (en) Therapeutic compounds
GB9904691D0 (en) Compounds useful in therapy
GB9912425D0 (en) Compounds useful in therapy
GB9910772D0 (en) Compounds useful in therapy
GB9921314D0 (en) Compounds useful in therapy
GB9910767D0 (en) Compounds useful in therapy
GB9910765D0 (en) Compounds useful in therapy
GB9910764D0 (en) Compounds useful in therapy
GB9910769D0 (en) Compounds useful in therapy
AU6884801A (en) Therapeutic compounds and methods

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)